• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper.

作者信息

Qin Hong, You Changqiao, Yan Feng, Tan Kefang, Xu Changgen, Zhao Rui, Ekpo Marlene Davis, Tan Songwen

机构信息

Research and Development Department, NanHua Bio-medicine CO., Ltd., Changsha, China.

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.

出版信息

Front Oncol. 2022 Dec 2;12:1062765. doi: 10.3389/fonc.2022.1062765. eCollection 2022.

DOI:10.3389/fonc.2022.1062765
PMID:36531041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9755875/
Abstract
摘要

相似文献

1
Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper.克服自然杀伤细胞疗法转化发展中的挑战：一篇观点论文。
Front Oncol. 2022 Dec 2;12:1062765. doi: 10.3389/fonc.2022.1062765. eCollection 2022.
2
Natural Killer Cells in Cancer and Cancer Immunotherapy.自然杀伤细胞在癌症和癌症免疫疗法中的作用。
Cancer Lett. 2021 Nov 1;520:233-242. doi: 10.1016/j.canlet.2021.07.032. Epub 2021 Jul 22.
3
Targeting Natural Killer Cells for Tumor Immunotherapy.靶向自然杀伤细胞进行肿瘤免疫治疗。
Front Immunol. 2020 Feb 19;11:60. doi: 10.3389/fimmu.2020.00060. eCollection 2020.
4
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.细胞因子在肿瘤微环境中协调自然杀伤细胞与髓系细胞的相互作用：对基于自然杀伤细胞的癌症免疫治疗的意义。
Front Immunol. 2021 Jan 29;11:621225. doi: 10.3389/fimmu.2020.621225. eCollection 2020.
5
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review).基于自然杀伤细胞的肺癌免疫治疗：挑战与展望（综述）。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8183. Epub 2021 Sep 9.
6
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.利用自然杀伤细胞免疫疗法靶向癌症干细胞。
Expert Opin Biol Ther. 2017 Mar;17(3):313-324. doi: 10.1080/14712598.2017.1271874. Epub 2016 Dec 23.
7
Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review.工程化纳米颗粒增强自然杀伤细胞活性用于肿瘤免疫治疗：综述。
Arch Pharm Res. 2020 Jan;43(1):32-45. doi: 10.1007/s12272-020-01218-1. Epub 2020 Jan 28.
8
Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy.阳离子纳米颗粒介导的自然杀伤细胞激活用于有效的癌症免疫治疗。
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):56731-56740. doi: 10.1021/acsami.0c16357. Epub 2020 Dec 8.
9
Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy.犬自然杀伤细胞在癌症免疫治疗中的特性及潜在应用
J Clin Med. 2019 Oct 27;8(11):1802. doi: 10.3390/jcm8111802.
10
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.自然杀伤细胞：癌症免疫治疗成功的关键。
Front Immunol. 2021 Apr 28;12:679117. doi: 10.3389/fimmu.2021.679117. eCollection 2021.

引用本文的文献

1
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment.过继性嵌合抗原受体（CAR）免疫细胞免疫疗法与多模式肿瘤治疗方法协同结合的进展。
Bioact Mater. 2024 Sep 10;42:379-403. doi: 10.1016/j.bioactmat.2024.08.046. eCollection 2024 Dec.

本文引用的文献

1
The phenotype of CD3-CD56 and CD3-CD56 natural killer cells in systemic lupus erythematosus patients and its relation to disease activity.系统性红斑狼疮患者中CD3-CD56和CD3-CD56自然杀伤细胞的表型及其与疾病活动的关系。
Reumatologia. 2022;60(4):258-265. doi: 10.5114/reum.2022.119042. Epub 2022 Sep 7.
2
Multifaceted characterization of the biological and transcriptomic signatures of natural killer cells derived from cord blood and placental blood.对源自脐带血和胎盘血的自然杀伤细胞的生物学和转录组特征进行多方面表征。
Cancer Cell Int. 2022 Sep 24;22(1):291. doi: 10.1186/s12935-022-02697-6.
3
Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?免疫治疗方案中对脐血来源的自然杀伤细胞的利用：仅仅是一个承诺吗？
Cancers (Basel). 2022 Sep 13;14(18):4439. doi: 10.3390/cancers14184439.
4
Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy by the Biological Macromolecule Cell-Wall Skeleton.生物大分子细胞壁骨架增强自然杀伤细胞介导的癌症免疫疗法。
Pathol Oncol Res. 2022 Aug 30;28:1610555. doi: 10.3389/pore.2022.1610555. eCollection 2022.
5
enhances natural killer cytolytic activity and anticancer efficacy and .增强自然杀伤细胞的细胞溶解活性和抗癌功效以及。（原英文句子表述似乎不完整）
Front Med (Lausanne). 2022 Aug 18;9:973681. doi: 10.3389/fmed.2022.973681. eCollection 2022.
6
Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者自然杀伤细胞 CD57 表达降低增强了其细胞毒性。
Front Immunol. 2022 Aug 17;13:912961. doi: 10.3389/fimmu.2022.912961. eCollection 2022.
7
Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials.临床转化中的干细胞治疗脊髓损伤仍不成熟：基于 62 项临床试验的单臂荟萃分析结果。
BMC Med. 2022 Sep 5;20(1):284. doi: 10.1186/s12916-022-02482-2.
8
Overcoming tumor resistance mechanisms in CAR-NK cell therapy.克服 CAR-NK 细胞治疗中的肿瘤耐药机制。
Front Immunol. 2022 Aug 3;13:953849. doi: 10.3389/fimmu.2022.953849. eCollection 2022.
9
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.ELK3 通过调节线粒体动力学调节自然杀伤细胞对三阴性乳腺癌的抗肿瘤疗效。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004825.
10
What Inhibits Natural Killers' Performance in Tumour.肿瘤如何抑制自然杀伤细胞的功能。
Int J Mol Sci. 2022 Jun 24;23(13):7030. doi: 10.3390/ijms23137030.